| Literature DB >> 27861265 |
Lindsy Meadowcraft1, Geoffrey Mospan, Taylor Morrisette, Katie Smart, Melissa Janis.
Abstract
In 2016, the FDA approved several new drugs for use in primary care. These drugs include amphetamine extended-release orally disintegrating tablets (Adzenys XR-ODT), elbasvir and grazoprevir (Zepatier), emtricitabine and tenofovir alafenamide (Descovy), glycopyrrolate and formoterol (Bevespi Aerosphere), insulin degludec injection (Tresiba), and ixekizumab (Taltz).Entities:
Year: 2016 PMID： 27861265 DOI： 10.1097/01.NPR.0000508167.22111.34
Source DB: PubMed Journal: Nurse Pract ISSN： 0361-1817